Dr. Gandras is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Community Drive
Ground Floor
Manhasset, NY 11030Phone+1 516-562-4677
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Vascular and Interventional Radiology, 1998 - 1999
New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 1998 - 1999- New York Presbyterian Hospital (Cornell Campus)Chief Residency, Radiology-Diagnostic, 1994 - 1998
Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 1993 - 1994
New York University School of MedicineClass of 1993
University of VirginiaBA, Chemistry with specialization in biological chemistry, 1985 - 1989
Certifications & Licensure
NY State Medical License 1994 - 2025- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Awards, Honors, & Recognition
- Fellow (FSIR) Society of Interventional Radiology
Clinical Trials
- Predicting the Safety and Effectiveness of Inferior Vena Cava Filters Start of enrollment: 2015 Oct 01
Publications & Presentations
PubMed
- 2 citationsEvaluation of a Hydrogel Liquid Embolic Agent in a Porcine Mesenteric Hemorrhage Model.Eric John Gandras, Timothy Jarrett, Raymond Lareau
Journal of Vascular and Interventional Radiology. 2022-06-01 - 15 citationsSignificance of elevated transplant renal artery velocities in the postoperative renal transplant patient.Eric Siskind, Pamela Lombardi, Mark Blum, Richard Tyrell, Manuel Villa
Clinical Transplantation. 2013-03-01 - 164 citationsPrevalence and Importance of Small Hepatic Lesions Found at CT in Patients with CancerLawrence H. Schwartz, Eric J. Gandras, Sandra M. Colangelo, Matthew C. Ercolani, David M. Panicek
Radiology. 1999-01-01
Press Mentions
Instylla Announces Positive Results from Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage ModelsJuly 28th, 2022
Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage modelsJuly 28th, 2022
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
